Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.
Jarratt D PytellAnthony T FojoJeanne C KerulyLaQuita N SnowOluwaseun Falade-NwuliaRichard D MooreGeetanjali ChanderCatherine R LeskoPublished in: Addiction science & clinical practice (2023)
PWH with OUD spend relatively little time receiving buprenorphine in their HIV primary care clinic. Concurrent cocaine use at buprenorphine initiation negatively impact time on buprenorphine.